Orhan Sezer

1985–2021 年に発表

82
論文数
25,274
被引用数
78
h 指数
82
i10 指数

被引用数

Orhan Sezer の年別被引用数1987 年: 被引用 1 件1988 年: 被引用 2 件1990 年: 被引用 1 件1991 年: 被引用 1 件1993 年: 被引用 1 件1994 年: 被引用 1 件1995 年: 被引用 1 件1996 年: 被引用 1 件1998 年: 被引用 1 件1999 年: 被引用 1 件2001 年: 被引用 8 件2002 年: 被引用 25 件2003 年: 被引用 55 件2004 年: 被引用 53 件2005 年: 被引用 56 件2006 年: 被引用 74 件2007 年: 被引用 105 件2008 年: 被引用 113 件2009 年: 被引用 176 件2010 年: 被引用 171 件2011 年: 被引用 232 件2012 年: 被引用 160 件2013 年: 被引用 208 件2014 年: 被引用 221 件2015 年: 被引用 193 件2016 年: 被引用 234 件2017 年: 被引用 192 件2018 年: 被引用 143 件2019 年: 被引用 669 件2020 年: 被引用 674 件2021 年: 被引用 636 件2022 年: 被引用 444 件2023 年: 被引用 223 件2024 年: 被引用 486 件2025 年: 被引用 185 件2026 年: 被引用 10 件1989 年は被引用が無いため表示していません1992 年は被引用が無いため表示していません1997 年は被引用が無いため表示していません2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,931 件、この内訳の 21.4%イギリス: 引用元論文 683 件、この内訳の 7.6%イタリア: 引用元論文 614 件、この内訳の 6.8%ドイツ: 引用元論文 611 件、この内訳の 6.8%フランス: 引用元論文 474 件、この内訳の 5.3%中国: 引用元論文 432 件、この内訳の 4.8%スペイン: 引用元論文 430 件、この内訳の 4.8%オランダ: 引用元論文 383 件、この内訳の 4.2%カナダ: 引用元論文 301 件、この内訳の 3.3%ギリシャ: 引用元論文 287 件、この内訳の 3.2%オーストラリア: 引用元論文 232 件、この内訳の 2.6%ベルギー: 引用元論文 225 件、この内訳の 2.5%
0%21.4%その他 26.7%

分野

  • Medicine75.2%
  • Biochemistry, Genetics and Molecular Biology20.2%
  • Immunology and Microbiology0.9%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • Health Professions0.8%
  • Engineering0.4%
  • その他1.6%

トピック

  • Multiple Myeloma Research and Treatments17.9%
  • Protein Degradation and Inhibitors6.5%
  • Amyloidosis: Diagnosis, Treatment, Outcomes4.8%
  • Peptidase Inhibition and Analysis4.2%
  • Cancer Treatment and Pharmacology2.6%
  • Bone health and treatments2%
  • その他62%

共著者

全論文

検索で開く
  1. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert A. Kyle, Kenneth C. Anderson, Brian G.M. Durie, Jesús F. San Miguel - The Lancet Oncology 2014 被引用: 4,869

  2. Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

    著者: , , , , , , , , , , , , , , , , , , , , , - Blood 2011 被引用: 1,034

  3. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis

    著者: , , , , , , , , , , , , - American Journal of Hematology 2005 被引用: 1,422

  4. Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Katja Weisel, Rachid Baz, Vânia Hungria, Jesús G. Berdeja, Fernando Leal da Costa, Ângelo Maiolino, Anders Waage, David H. Vesole, Enrique M. Ocio, Hang Quach, Christoph Driessen, Joan Bladé, Xavier Leleu, Eloísa Riva, P. Leif Bergsagel, Jian Hou, Wee Joo Chng, Ulf‐Henrik Mellqvist, Dominik Dytfeld, Jean‐Luc Harousseau, Hartmut Goldschmidt, Jacob P. Laubach, Nikhil C. Munshi, Francesca Gay, Meral Beksaç, Luciano J. Costa, Martin Kaiser, Parameswaran Hari, Mario Boccadoro, Saad Z. Usmani, Sonja Zweegman, Sarah A. Holstein, Orhan Sezer, Simon J. Harrison, Hareth Nahi, Gordon Cook, María‐Victoria Mateos, S. Vincent Rajkumar, Meletios Α. Dimopoulos, Paul G. Richardson - The Lancet Oncology 2021 被引用: 268

  5. Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer

    著者: , , , , , , , , , , , , - European Journal of Cancer 2009 被引用: 454

  6. Expert review on soft‐tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pieter Sonneveld, Saad Z. Usmani, Karin Vanderkerken, David H. Vesole, Anders Waage, Sonja Zweegman, Paul G. Richardson, Joan Bladé - British Journal of Haematology 2021 被引用: 174

  7. European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Haematologica 2015 被引用: 398

  8. Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rafaël Fonseca, Giampaolo Merlini, Juan José Lahuerta, Joan Bladé, Robert Z. Orlowski, Jatin J. Shah, on behalf of the International Myeloma Working Group - Leukemia 2012 被引用: 383

  9. Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mario Boccadoro, Brian G.M. Durie, Pieter Sonneveld, M. A. Hussein, on behalf of the International Myeloma Working Group - Leukemia 2007 被引用: 839

  10. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , R Powles, S. Vincent Rajkumar, Brian G.M. Durie, on behalf of the International Myeloma Working Group - Leukemia 2008 被引用: 809

  11. Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , C Anderson Kenneth, Michael Attal, Hervé Avet‐Loiseau, Ashraf Badros, Dalsu Baris, Bart Barlogie, Régis Bataille, Meral Beksaç, Andrew Belch, Dina Ben‐Yehuda, Bill Bensinger, P. Leif Bergsagel, Jenny Bird, Joan Bladé, Mario Boccadoro, Michèle Cavo, Asher Chanan‐Khan, Wen Ming Chen, Tony Child, James Chim, Wee Joo Chng, Ray Comenzo, John Crowley, William S. Dalton, Faith E. Davies, Cármino Antônio De Souza, Michel Delforge, Meletios Α. Dimopoulos, Angela Dispenzieri, Johannes Drach, Matthew T. Drake, Brian G.M. Durie, Hermann Einsele, Theirry Facon, Dorotea Fantl, Jean‐Paul Fermand, Rafaël Fonseca, Gösta Gahrton, Ramón García‐Sánz, Christina Gasparetto, Morie A. Gertz, John Gibson, Sergio Giralt, Hartmut Goldschmidt, Philip R. Greipp, Roman Hájek, Izhar Hardan, Parameswaran Hari, Jean‐Luc Harousseau, Hiroyuki Hata, Yutaka Hattori, Tom Heffner, Joy Ho, Vânia Hungria, Shinsuke Ida, Peter Jacob, Sundar Jagannath, Hans Erik Johnsen, Jian Hou, Douglas Joshua, Artur Jurczyszyn, Michio Kawano, Nicolaus Kröger, Shaji Kumar, Robert A. Kyle, Martha Q. Lacy, Juan José Lahuerta, Ola Landgren, Jacob P. Laubach, Jae Hoon Lee ほか 60 名 - Leukemia 2011 被引用: 721

  12. Role of Magnetic Resonance Imaging in the Management of Patients With Multiple Myeloma: A Consensus Statement

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2015 被引用: 394

  13. Second primary malignancies in multiple myeloma: an overview and IMWG consensus

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Evangelos Terpos, Ingemar Turesson, Saad Z. Usmani, Brendan M. Weiss, Antonio Palumbo - Annals of Oncology 2016 被引用: 151

  14. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer

    著者: , , , , , , , , , , , , - European Journal of Cancer 2004 被引用: 225

  15. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer

    著者: , , , , , , , , , , - European Journal of Cancer 2003 被引用: 415

  16. Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Meletios Α. Dimopoulos, Philippe Moreau, Robert Z. Orlowski, Jesús F. San Miguel, Kenneth C. Anderson, Antonio Palumbo, Shaji Kumar, S. Vincent Rajkumar, Brian G.M. Durie, Paul G. Richardson - Leukemia 2015 被引用: 255

  17. Assessing quality of life in patients with colorectal cancer: An update of the EORTC quality of life questionnaire

    著者: , , , , , , , , , - European Journal of Cancer 2007 被引用: 216

  18. International Myeloma Working Group molecular classification of multiple myeloma: spotlight review

    著者: , , , , , , , , , , , , , , , , , , , , , - Leukemia 2009 被引用: 878

  19. Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Hematology & Oncology 2018 被引用: 322

  20. Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the International Myeloma Working Group

    著者: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2010 被引用: 409

  21. Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2009 被引用: 233

  22. Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer

    著者: , , , , , , , , - European Journal of Cancer 2001 被引用: 201

  23. The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network

    著者: , , , , , , , , , , , , , , , , , , , - Haematologica 2014 被引用: 174

  24. International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma

    著者: , , , , , , , , , , , , , - Leukemia 2009 被引用: 482